USCWA
TECH icon

U.S. Capital Wealth Advisors’s Bio-Techne TECH Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,504
Closed -$206K – 1078
2025
Q4 		$206K Buy
+3,504
New +$213K 0.01% 922

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

U.S. Capital Wealth Advisors's TECH Position: Q1 2026 in Review

U.S. Capital Wealth Advisors sold out of Bio-Techne (TECH) in Q1 2026, closing a stake of 3,504 shares — an estimated $206K sold.

U.S. Capital Wealth Advisors first reported a position in TECH in Q4 2025 and held it in 1 quarter. The position peaked at $206K in Q4 2025. 584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • U.S. Capital Wealth Advisors reported no remaining Bio-Techne position as of Q1 2026 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 3,504 Bio-Techne shares in Q1 2026, an estimated $206K.
  • U.S. Capital Wealth Advisors first reported a position in Bio-Techne in Q4 2025 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Bio-Techne position peaked at $206K in Q4 2025.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.